Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ:AMGN)

271.90 +0.56 (+0.21%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
53 54 Next >
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SVB, Amgen, Signature, and Norfolk Southern and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Amgen Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AMGN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit Regulatory Compliance
Exposures Financial Legal Regulatory
1 Dividend Growth Stock to Buy Hand Over Fist
Investing in dividend stocks, particularly those that raise their payouts regularly, can pay off massively in time. 
Via The Motley Fool
Amgen's Debt Overview
Via Benzinga
A Look Into Amgen Inc's Price Over Earnings
Via Benzinga
Looking At Amgen's Recent Unusual Options Activity
Via Benzinga
Amgen Options Traders Betting On Stock Rising This Much By April Expiration
Within the next month, Amgen Inc. (NASDAQ: AMGN) is expected to report quarterly earnings at $4 per share on revenue of $6.26 billion, analysts say. 
Via Benzinga
This Blue Chip Dividend Stock Should Return to Form When the Risk Premium Flips
T-bills may be the flavor of the month, but history has shown this top biotech stock is a far better long-term investment. 
Via The Motley Fool
The Government Move That Could Drive Obesity Drugs — And Lilly, Novo Shares
The decision from the WHO could further bolster use of Novo's Saxenda and Wegovy. 
Via Investor's Business Daily
Up 463%, This Sizzling Growth Stock Could Have a Lot More Room to Run
Viking Therapeutics stock might in the midst of a historic run. 
Via The Motley Fool
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Amgen Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AMGN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit Regulatory Compliance
Exposures Financial Legal Regulatory
Viking Therapeutics' Initial VK2735 'Data Resoundingly Beat Expectations,' Analyst Says
Earlier today, Viking Therapeutics Inc (NASDAQ: VKTX) announced the first-in-human single-ascending dose and multiple-ascending dose data of VK2735. 
Via Benzinga
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Clinical-stage biotechnology company Viking Therapeutics, Inc. (NASDAQ: VKTX) stock jumped more than 50% on positive Phase 1 data on its novel dual GLP-1/GLP 
Via MarketBeat
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Match, DraftKings, SVB, and Amgen and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Amgen Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AMGN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit Regulatory Compliance
Exposures Financial Legal Regulatory
The Ozempic Obesity Battle Is Heating Up With Novo Scoring A Fresh Win
The company is working on an oral version of its cult-following injection, Ozempic. 
Via Investor's Business Daily
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DraftKings, SVB, Amgen, and Signature and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Amgen Inc. (AMGN)
From Glancy Prongay & Murray LLP
Via Business Wire
Nvidia's Artificial Intelligence Market Strategy Impresses Wall Street
Analysts on Wednesday praised Nvidia's approach to artificial intelligence as it moves deeper into software and services. NVDA stock rose. 
Via Investor's Business Daily
Amgen Inc. (AMGN) Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Amgen Inc.
From Robbins LLP
Via Business Wire
Nvidia Ramps Up Artificial Intelligence Offerings Amid AI's 'iPhone Moment'
Nvidia on Tuesday demonstrated how its technology is advancing artificial intelligence in myriad industries. Nvidia stock has soared in 2023. 
Via Investor's Business Daily
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Amgen Inc. (AMGN)
From Law Offices of Howard G. Smith
Via Business Wire
These Are The Top 3 Large Caps For Yield And Dividend Growth
You can use Marketbeat's Dividend Screener to find top dividend growth stocks with yields above 3% and value for investors. 
Via MarketBeat
Topics Economy
Exposures Interest Rates
3 Dow Stocks Near 52-Week Lows That Look Like Bargains Now
These businesses are performing much better than their stock prices would suggest. 
Via The Motley Fool
AMGEN INC. (NASDAQ: AMGN) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Amgen Inc. (NASDAQ: AMGN)
From Bernstein Liebhard LLP
Via GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Amgen Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AMGN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit Regulatory Compliance
Exposures Financial Legal Regulatory
AMGN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Files Securities Class Action Lawsuit Against Amgen Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Match, Credit Suisse, SVB, and Amgen and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Notifies Amgen Inc. (AMGN) Investors of Class Action and to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
53 54 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.